Dynavax Technologies Corporation (DVAX) EPS by Year
DVAXNASDAQ
Dynavax Technologies Corporation earned $0.20 per diluted share in fiscal year 2024. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2024 through Q3 FY2025, the same line adds up to a loss of $0.37 per diluted share. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Dynavax Technologies Corporation has filed alongside them.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.
Dynavax Technologies Corporation earned $0.20 per diluted share in fiscal year 2024.
Dynavax Technologies Corporation (DVAX) reported a loss of $0.05 per diluted share in fiscal year 2023 and $0.20 per diluted share in fiscal year 2024. A growth rate is not meaningful here, because the earlier figure was zero or negative.
Dynavax Technologies Corporation (DVAX) reported a loss of $0.37 per diluted share over the trailing 12 months, Q4 FY2024 through Q3 FY2025, summed from the four most recent quarterly filings.
Across the 15 fiscal years this page covers, Dynavax Technologies Corporation (DVAX) diluted earnings per share went from -$0.69 in fiscal year 2010 to $0.20 in fiscal year 2024.
Dynavax Technologies Corporation (DVAX) reported $0.21 in diluted earnings per share in Q3 2025. This represents an increase of 75.0% from the same quarter a year earlier.
Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Dynavax Technologies Corporation (DVAX) reported on that line in every period on record.
